DeepMed Research

DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers

Not Applicable

Completed

Conditions: Palpable Breast Cancer

Interventions: Device: Breast Cancer Locator (BCL)

First Posted Date: 2018-06-29

Last Posted Date: 2021-05-25

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 18

Registration Number: NCT03573661

Locations: 🇺🇸
St. Joseph Hospital, Nashua, New Hampshire, United States
🇺🇸
Cheshire Medical Center, Keene, New Hampshire, United States
🇺🇸
Lahey Hospital & Medical Center (Lahey Clinic), Burlington, Massachusetts, United States

and more 1 locations

The Prone to Supine Breast MRI Trial

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Prone to Supine MRI

First Posted Date: 2018-06-29

Last Posted Date: 2021-08-30

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 72

Registration Number: NCT03573804

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Improving Sleep in Cancer Patients: A Feasibility Trial

Not Applicable

Completed

Conditions: Cancer
Insomnia

Interventions: Behavioral: CBT-I

First Posted Date: 2018-06-19

Last Posted Date: 2019-04-11

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 10

Registration Number: NCT03561064

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

IMPROVE AKI Cluster-Randomized Trial

Not Applicable

Completed

Conditions: Acute Kidney Injury

Interventions: Behavioral: AKI Prevention Toolkit
Behavioral: Technical Assistance (TA)
Behavioral: Virtual Learning Collaborative (VLC)
Behavioral: Automated Surveillance Reporting (ASR)

First Posted Date: 2018-06-14

Last Posted Date: 2025-03-18

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 10252

Registration Number: NCT03556293

Locations: 🇺🇸
White River Junction VA, White River Junction, Vermont, United States
🇺🇸
Tennesee Valley VA, Nashville, Tennessee, United States

A Pilot Study of Creative Arts Interventions for Neurology Inpatients

Not Applicable

Completed

Conditions: Migraine
Epilepsy

Interventions: Other: Art Intervention

First Posted Date: 2018-05-11

Last Posted Date: 2018-07-18

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 33

Registration Number: NCT03520777

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)

Not Applicable

Terminated

Conditions: Lung Cancer

Interventions: Behavioral: Remotely Supervised Exercise (REM)
Behavioral: Unsupervised Exercise (UNSUP)

First Posted Date: 2018-04-18

Last Posted Date: 2021-02-02

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 4

Registration Number: NCT03500393

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Hanover, New Hampshire, United States

Family Planning Ahead

Not Applicable

Terminated

Conditions: Pregnancy Related
Contraception

Interventions: Other: Postpartum Birth Control
Other: Birth Control After Pregnancy

First Posted Date: 2018-04-18

Last Posted Date: 2019-01-09

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 41

Registration Number: NCT03500952

Locations: 🇺🇸
Internet (Dartmouth College), Lebanon, New Hampshire, United States

Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares

Phase 2

Completed

Conditions: Colitis, Ulcerative

Interventions: Other: Hyperbaric Oxygen Therapy

First Posted Date: 2018-04-11

Last Posted Date: 2021-02-08

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 39

Registration Number: NCT03494764

Locations: 🇺🇸
UC San Diego Health Systems, La Jolla, California, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
University of California San Diego, San Diego, California, United States

and more 5 locations

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Phase 3

Active, not recruiting

Conditions: Lymphoma
Myelodysplasia
Plasma Cell Disorder
Acute Myeloid Leukemia
Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Myeloproliferative Disorder
Myelofibrosis

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Radiation: Total Body Irradiation
Drug: Tacrolimus
Drug: cellcept
Drug: g-csf
Procedure: Peripheral Blood Transplant

First Posted Date: 2018-03-29

Last Posted Date: 2024-07-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 21

Registration Number: NCT03480360

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Other: Quality Improvement

First Posted Date: 2018-03-29

Last Posted Date: 2021-05-07

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 694

Registration Number: NCT03480854

Locations: 🇺🇸
Massachusetts General Hospital Multiple Sclerosis Center, Boston, Massachusetts, United States
🇺🇸
Concord Hospital, Concord, New Hampshire, United States
🇺🇸
University of Vermont Multiple Sclerosis Center, Burlington, Vermont, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy